Evidence map›Paper›PMID 11109299›Full record

ReviewJournal of psychiatry & neuroscience : JPN2000

Neurochemical and metabolic aspects of antidepressants: an overview.

G B Baker, R T Coutts, A J Greenshaw

Open access · greenAbstract readReview
In one paragraph

Review in Journal of psychiatry & neuroscience : JPN, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Tranylcypromine: new perspectives on an "old" drug.European archives of psychiatry and clinical neuroscience · 2006
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

G B BakerNeurochemical Research Unit, Department of Psychiatry, University of Alberta, Edmonton, Alta. glen.baker@ualberta.ca
R T Coutts
A J Greenshaw
University of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antidepressants, in addition to being effective therapeutic agents for depression, have also proved to be multifaceted drugs useful for treating a number of other psychiatric and neurologic disorders. Despite the widespread use of these drugs, much remains to be understood about their mechanisms of action and other important aspects, such as their metabolism and potential interactions with other drugs. This article reviews research conducted in the authors' laboratories on various aspects of antidepressants, including trace amines and antidepressants, gamma-aminobutyric acid and antidepressants, drug metabolism, development and application of rapid, sensitive assay procedures for antidepressants and their metabolites; and drug development based on analogues of the antidepressants phenelzine and tranylcypromine. The significance of this work to future drug development is also discussed.

Indexed as

AnimalsAntidepressive AgentsBiogenic AminesBiological AssayBrain ChemistryCytochrome P-450 Enzyme SystemDrug Designgamma-Aminobutyric AcidHumansAntidepressive AgentsBiogenic AminesCytochrome P-450 Enzyme Systemgamma-Aminobutyric Acid

Identifiers

PMID11109299
PMCPMC1408023
OpenAlexW2167282979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.